Stock Track | Teladoc Surges 5% on Upbeat Q3 Results, Analysts Remain Cautious

Stock Track11-01

Shares of Teladoc Health Inc. (TDOC) soared 5.22% on November 1st, after the telehealth company reported better-than-expected third-quarter earnings results. The stock gained despite analysts' mixed reactions and concerns over Teladoc's revenue outlook.

For the third quarter, Teladoc reported revenue of $641 million, in line with analysts' expectations. However, the company posted a smaller-than-anticipated loss of $0.19 per share, beating estimates and fueling the stock rally.

Following the results, some analysts slightly raised their earnings forecasts for 2025, but maintained a cautious stance on the company's prospects. Deutsche Bank, for instance, lifted its price target on Teladoc to $12 from $10 but kept a "Hold" rating, citing uncertainty over the company's future performance.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment